Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Primera Biosystems has closed on $21 million of Series B financing led by Abingworth and joined by Interwest Partners. Existing investors Malaysian Technology Development Corporation, MPM Capital, Burrill & Company and the Invus Group also participated in the round.
Subscribe to our email newsletter
Primera’s new board of directors will be led by Laurence McCarthy as executive chairman and will include Martin Verhoef, president and CEO; Michael Bigham and Vincent Miles, Abingworth; Nina Kjellson, Interwest; Azlin Alias, Malaysian Technology Development Corporation and Kazumi Shiosaki (co-founder), MPM Capital.
Mr Verhoef said: “Primera plans to use this financing to complete development of our instrument system, reagent kits for disease-specific clinical research, future diagnostic tests as well as support ongoing R&D efforts. With help from new and existing investors, we will stay ahead of the field by developing molecular diagnostics that have significant impact on patient management and deliver real benefits for doctors, patients and payers.”